LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)

LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TP2147-5mg 5 mg

7 - 10 business days*

77.00€
TGM-TP2147-10mg 10 mg

7 - 10 business days*

110.00€
TGM-TP2147-25mg 25 mg

7 - 10 business days*

218.00€
TGM-TP2147-50mg 50 mg

7 - 10 business days*

323.00€
TGM-TP2147-100mg 100 mg

7 - 10 business days*

470.00€
 
Description: LSKL, Inhibitor of Thrombospondin (TSP-1) TFA, a tetrapeptide derived from... more
Product information "LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)"
Description: LSKL, Inhibitor of Thrombospondin (TSP-1) TFA, a tetrapeptide derived from latency-associated protein (LAP)-TGFbeta, acts as a competitive antagonist of TGF-beta1. Target: Others. References: Liao F, et al. LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-beta1 signaling activity following subarachnoid hemorrhage in rats. Exp Ther Med. 2016 Oct,12(4):2537-2543. Epub 2016 Aug 31.
Supplier: TargetMol
Supplier-Nr: TP2147

Properties

Conjugate: No
MW: 572.62 D
Formula: C23H43F3N6O7

Database Information

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)"
Write a review
or to review a product.
Viewed